Announcements Trials
Browse Landscape

Phase

Phase 2 83Phase 1 18Phase 1/2 12Phase 3 11Phase NA 9Phase 2/3 3Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 2Recurrence 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Lymphoid 1Leukemia 1Hematologic Neoplasms 1

Interventions

posaconazole 2fludarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1eltrombopag 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Micafungin 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Cytarabine 1Cholecalciferol 1Bone Marrow Transplantation 1Azacitidine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Myelodysplastic Syndromes × Busulfan × Clear all
NCT00361140 2017-03-03

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

H. Lee Moffitt Cancer Center and Research Institute

Phase 4 Completed
72 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01339988 2011-04-21

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
10 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡